Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Astrocytic network alterations have been reported in Alzheimer's disease (AD), but the underlying pathways have remained undefined. Here we measure astrocytic calcium, cerebral blood flow and amyloid-β plaques in vivo in a mouse model of AD using multiphoton microscopy. We find that astrocytic hyperactivity, consisting of single-cell transients and calcium waves, is most pronounced in reactive astrogliosis around plaques and is sometimes associated with local blood flow changes. We show that astroglial hyperactivity is reduced after P2 purinoreceptor blockade or nucleotide release through connexin hemichannels, but is augmented by increasing cortical ADP concentration. P2X receptor blockade has no effect, but inhibition of P2Y1 receptors, which are strongly expressed by reactive astrocytes surrounding plaques, completely normalizes astrocytic hyperactivity. Our data suggest that astroglial network dysfunction is mediated by purinergic signalling in reactive astrocytes, and that intervention aimed at P2Y1 receptors or hemichannel-mediated nucleotide release may help ameliorate network dysfunction in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, astrocytes in apposition to Aβ deposits are also 'hyperactive' and display higher resting Ca 2+ level, more frequent and larger Ca 2+ elevations, long-range coordinated Ca 2+ waves that are never seen in control mice 95, 98, 111 , as well as increased gliotranmission 112 .”
From Astrocyte function from information processing to cognition and cognitive impairment (2019) · cites this paper as [98]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“mGlu5 receptors 97 and P2Y1 receptors 98 , whose enhanced Gq-IP3-dependent Ca 2+ signaling can similarly contribute to astrocytic Ca 2+ alteration”
From Astrocyte function from information processing to cognition and cognitive impairment (2019) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · cited 1×
“In one astrocyte, spontaneous calcium activity occurs first in the soma (1) and subsequently propagates into an endfoot (2).”
BackgroundAstrocytes, from brain glue to communication elements: the revolution continues
Volterra, A., & Meldolesi, J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1722 · Cited by 1,770
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Astrocyte-mediated control of cerebral blood flow
Takano, T., Tian, G.-F., Peng, W., Lou, N., Libionka, W., Han, X., & Nedergaard, M. (2006) · Nature Neuroscience · doi:10.1038/nn1623 · Cited by 1,141
Cited by
Items 101–200 of 332
Rocchio, F., Tapella, L., Manfredi, M., Chisari, M., Ronco, F., Ruffinatti, F. A., Conte, E., Canonico, P. L., Sortino, M. A., Grilli, M., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2451-y · Cited by 48
Brain Disorders and Chemical Pollutants: A Gap Junction Link?
Mesnil, M., Defamie, N., Naus, C. C. G., & Sarrouilhe, D. (2020) · Biomolecules · doi:10.3390/biom11010051 · Cited by 52
“Such activation leads to ATP and glutamate release with neurotoxic effects [443,444,503].”
BackgroundWellmann, M., Álvarez‐Ferradas, C., Maturana, C. J., Sáez, J. C., & Bonansco, C. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00446 · Cited by 43
Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease
Guillemaud, O., Ceyzériat, K., Saint-Georges, T., Cambon, K., Petit, F., Haim, L. B., Sauvage, M.-A. C.-D., Guillermier, M., Bernier, S., Hérard, A., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.010 · Cited by 45
Angeli, S., Kousiappa, I., Stavrou, M., Sargiannidou, I., Georgiou, E., Papacostas, S., & Kleopa, K. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.582934 · Cited by 46
Bossuyt, J., Herrewegen, Y. V. D., Nestor, L., Buckinx, A., Bundel, D. D., & Smolders, I. J. (2023) · Glia · doi:10.1002/glia.24390 · Cited by 44
Mechanism and consequence of abnormal calcium homeostasis in Rett syndrome astrocytes
Dong, Q., Liu, Q., Li, R., Wang, A., Bu, Q., Wang, K. H., & Chang, Q. (2018) · eLife · doi:10.7554/elife.33417 · Cited by 41
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
Santiago-Balmaseda, A., Aguirre-Orozco, A., Valenzuela-Arzeta, I. E., Villegas-Rojas, M. M., Pérez‐Segura, I., Jiménez-Barrios, N., Hurtado-Robles, E., Rodríguez-Hernández, L. D., Rivera-German, E. R., Guerra‐Crespo, M., et al. (2024) · Cells · doi:10.3390/cells13110921 · Cited by 49
“Growing evidence suggests that reactive astrocytes are primarily located in the microenvironment of amyloid plaques [125–127].”
BackgroundAlves, M., García, L. D. D., Conte, G., Jimenez-Mateos, E. M., D’Orsi, B., Sanz‐Rodriguez, A., Prehn, J. H. M., Henshall, D. C., & Engel, T. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0089-19.2019 · Cited by 45
“, 2018) and chronic diseases of the CNS, such as Alzheimer’s disease (Delekate et al., 2014) and epilepsy (Alves et al.”
BackgroundResultInfluentialEssential Role of Astrocytes in Learning and Memory
Escalada, P., Ezkurdia, A., Ramírez, M. J., & Solas, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031899 · Cited by 49
“In certain mouse models, such as APPPS1 mice, this elevated activity involves abnormal purinergic Ca 2+ signalling [117,118], although recent research has also indicated a decrease in sensory-evoked astrocyte responsiveness in AD mice with APP and PS1 mutations [119].”
BackgroundAstrocytes: The Stars in Neurodegeneration?
Dittlau, K. S., & Freude, K. (2024) · Biomolecules · doi:10.3390/biom14030289 · Cited by 42
“In multiple neurodegenerative diseases including AD [42,98–102], ALS [103,104], HD [105–107] and PD [29,108], calcium dyshomeostasis is observed.”
InfluentialPurinergic signaling in Alzheimer’s disease
Erb, L., Woods, L. T., Khalafalla, M. G., & Weisman, G. A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.014 · Cited by 39
Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective
Hu, Z., Zhang, Y., Yu, W., Li, J., Yao, J., Zhang, J., Wang, J., & Wang, C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115392 · Cited by 40
Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction
Ajenikoko, M. K., Ajagbe͓, A. O., Onigbinde, O. A., Okesina, A. A., & Tijani, A. A. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.11.005 · Cited by 44
Pham, C., Hérault, K., Oheim, M., Maldera, S., Vialou, V., Cauli, B., & Li, D. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01146-1 · Cited by 43
Sompol, P. M., Gollihue, J. L., Weiss, B. E., Lin, R., Case, S. L., Kraner, S. D., Weekman, E. M., Gant, J. C., Rogers, C. B., Niedowicz, D. M., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1333-22.2023 · Cited by 36
“HHcy is associated with dysregulation of astrocyte Ca21 signaling Dysregulation of astrocytic Ca21 signaling has been reported in mouse models of amyloid pathology and acute brain injury (Kuchibhotla et al., 2009; Delekate et al., 2014).”
BackgroundInfluentialSaito, K., Shigetomi, E., Yasuda, R., Sato, R., Nakano, M., Tashiro, K., Tanaka, K. F., Ikenaka, K., Mikoshiba, K., Mizuta, I., et al. (2018) · Glia · doi:10.1002/glia.23300 · Cited by 40
“…Ca21 signals in pathophysiological conditions, including in models of neurological disease such as epilepsy, ischemia, Alzheimer disease and Huntington disease (Ding et al., 2007; Ding, Wang, Cui, & Haydon, 2009; Kuchibhotla et al., 2009; Delekate et al., 2014; Jiang et al., 2016), but not AxD.”
BackgroundInfluentialAstrocyte subtype-specific approach to Alzheimer's disease treatment
Sarkar, S., & Biswas, S. C. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104956 · Cited by 40
Purinergic neurone-glia signalling in cognitive-related pathologies
Illés, P., & Verkhratsky, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.005 · Cited by 37
Shigetomi, E., Suzuki, H., Hirayama, Y. J., Sano, F., Nagai, Y., Yoshihara, K., Koga, K., Tateoka, T., Yoshioka, H., Shinozaki, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50190-7 · Cited by 39
“In the present study, we focused on the P2Y1R-mediated signaling pathway, which is commonly altered inseveral neurologicaldisorders such as epilepsy, stroke, AD, and traumatic brain injury 25 – 33 .”
BackgroundInfluentialAge- and Experience-Related Plasticity of ATP-Mediated Signaling in the Neocortex
Lalo, U., Bogdanov, A., & Pankratov, Y. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00242 · Cited by 35
Shi, A., Petrache, A. L., Shi, J., & Ali, A. B. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz165 · Cited by 38
“It has been well documented that astrocyte hyperactivity is prominent around Aβ plaques and produces synchronous hyperactivity in [Ca2+]i transients across long distances that is uncoupled from neuronal activity (Kuchibhotla et al. 2009; Delekate et al. 2014).”
BackgroundAn Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse Models
Spanos, F., & Liddelow, S. A. (2020) · Cells · doi:10.3390/cells9112415 · Cited by 34
“Neurotoxicity, disrupted aquaporin 4 (AQP4) polarization, and altered Ca2+ signaling are some of the ways AD-associated gene mutations impede normal astrocyte function, which in turn are proposed to negatively impact neuronal health and function [30,39,40].”
BackgroundRocchio, F., Tapella, L., Manfredi, M., Chisari, M., Ronco, F., Ruffinatti, F. A., Conte, E., Canonico, P. L., Sortino, M. A., Grilli, M., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1264-8 · Cited by 36
Role of P2Y receptors in astrocyte physiology and pathophysiology
Lohr, C. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109311 · Cited by 31
Glial polarization in neurological diseases: Molecular mechanisms and therapeutic opportunities
Liu, Y., Wu, L., Peng, W., & Mao, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102638 · Cited by 36
Astrocytic Pathological Calcium Homeostasis and Impaired Vesicle Trafficking in Neurodegeneration
Vardjan, N., Verkhratsky, A., & Zorec, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020358 · Cited by 34
“The underlying cause of increased Ca2+ excitability of astrocytes from AD model mice may be an elevated ATP release from reactive astrocytes that leads to over-activation of P2Y1 purinergic receptors [162].”
BackgroundThe Role of Glial Cells and Synapse Loss in Mouse Models of Alzheimer’s Disease
Ziegler-Waldkirch, S., & Meyer-Luehmann, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00473 · Cited by 21
Exploring the Role of P2X Receptors in Alzheimer’s Disease
Godoy, P. A., Ramírez-Molina, O., & Fuentealba, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01330 · Cited by 31
Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
Merighi, S., Poloni, T. E., Terrazzan, A., Moretti, E., Gessi, S., & Ferrari, D. (2021) · Cells · doi:10.3390/cells10051267 · Cited by 33
“Accordingly, inhibition of the P2Y1 receptor normalized the astroglial network dysfunction [169].”
BackgroundLiu, R., Collier, J. M., Abdul‐Rahman, N., Capuk, O., Zhang, Z., & Begum, G. (2024) · Aging and Disease · doi:10.14336/ad.2023.1201 · Cited by 42
“The activation of astroglial purinergic receptors is also implicated in these aberrant Ca 2+ changes and an increased frequency of astroglial Ca 2+ oscillations in the pre plaque stage is associated with instability of BBB ECs affecting the vascular tone and local blood flow [199, 200].”
BackgroundHao, T., Du, X., Yang, S., Zhang, Y., & Liang, F. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118099 · Cited by 28
Castro, M. A. D., & Volterra, A. (2021) · Glia · doi:10.1002/glia.24128 · Cited by 32
A Dichotomous Role for FABP7 in Sleep and Alzheimer’s Disease Pathogenesis: A Hypothesis
Needham, H., Torpey, G., Flores, C. C., Davis, C. J., Vanderheyden, W. M., & Gerstner, J. R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.798994 · Cited by 29
Fordsmann, J. C., Nielsen, R. M., Cai, C., Brazhe, A., Thomsen, K. J., Zambach, S. A., Lønstrup, M., Lind, B. L., & Lauritzen, M. (2018) · Glia · doi:10.1002/glia.23506 · Cited by 30
“The activity levels in astrocytes found in our work are in line with previous findings using similar methods (Delekate et al., 2014; Takata & Hirase, 2008).”
ResultAstroglial connexins and cognition: memory formation or deterioration?
He, J., Xiao-Yan, L. I., Yang, L., & Zhao, X. (2020) · Bioscience Reports · doi:10.1042/bsr20193510 · Cited by 29
Barnett, D., Bohmbach, K., Grelot, V., Charlet, A., Dallérac, G. M., Ju, Y. H., Nagai, J., & Orr, A. G. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1376-23.2023 · Cited by 28
Li, M., Xu, J., Li, L., Zhang, L., Zuo, Z., Feng, Y., He, X., & Hu, X. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114770 · Cited by 29
The complex effects of miR-146a in the pathogenesis of Alzheimer’s disease
Long, Y., Liu, J., Wang, Y., Guo, H.-D., & Cui, G.-H. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01566 · Cited by 39
Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View
Huffels, C. F. M., Middeldorp, J., & Hol, E. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03699-6 · Cited by 30
“Given that reactive astrocytes display enhanced calcium-wave activity [104, 105], astrocyte glutamate and D-serine release are characteristically upregulated in AD pathogenesis [155, 156].”
BackgroundMontagna, E., Crux, S., Luckner, M., Herber, J., Colombo, A. V., Marinković, P., Tahirović, S., Lichtenthaler, S. F., Wanner, G., Müller, U., et al. (2019) · Glia · doi:10.1002/glia.23584 · Cited by 28
“Previous in vivo studies on anaesthetized AD mouse models overexpressing mutated APP reported hyperactivity of Ca signaling detected by a somatic Caindicator (Delekate et al., 2014; Kuchibhotla, Lattarulo, Hyman, & Bacskai, 2009).”
BackgroundInfluentialImpaired Hippocampal Neurovascular Coupling in a Mouse Model of Alzheimer’s Disease
Li, L., Tong, X., Kahnouei, M. H., Vallerand, D., Hamel, É., & Girouard, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715446 · Cited by 31
Adžić, M., Stevanović, I. D., Josipović, N., Laketa, D., Lavrnja, I. C., Bjelobaba, I. M., Bozic, I. D., Jovanović, M., Milosevic, M. M., & Nedeljković, N. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23950 · Cited by 29
“The actions of ATP through P2Y1R promote reactive astrogliosis upon mechanical injury (Franke et al., 2001), ischemic conditions (Sun et al., 2008), or Alzheimer disease (Delekate et al., 2014).”
BackgroundNanclares, C., Poynter, J., Martell-Martinez, H. A., Vermilyea, S., Araque, A., Kofuji, P., Lee, M. K., & Covelo, A. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02547-3 · Cited by 28
“Even though the specific mechanism remains to be elucidated, our results demonstrate that the A53T-mutant α-synuclein alters the astrocyte Ca2+ signal in situ, adding up to other studies showing dysfunctional astrocyte Ca2+ signaling in various neurological disorders, including other models of PD [10], Alzheimer’s dis…”
BackgroundAlternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
Valenza, M., Facchinetti, R., Menegoni, G., Steardo, L., & Scuderi, C. (2021) · Biomolecules · doi:10.3390/biom11040600 · Cited by 26
Islam, J., Cho, J., Kim, J.-Y., Park, K., Koh, Y.-J., Chung, C. Y., Lee, E., Nam, S. J., Lee, K., Kim, S.-H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.766919 · Cited by 28
“Apyrase blocks the activation of N3I by Ab (31), suggesting that the ATP-P2X7R interaction is crucial in N3I activation in response to Ab (32).”
BackgroundAstrocytes: new evidence, new models, new roles
Brazhe, A., Verisokin, A. Y., Вячеславовна, В. Д., & Postnov, D. E. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01145-7 · Cited by 29
“Abnormal astrocytic calcium activity in pathology can aggravate neuronal network dysfunction, while suppressing it can ameliorate such detrimental effects, suggesting astrocytes as potential targets for pharmacology in neurodegenerative neuropatholo-gies (Delekate et al. 2014).”
BackgroundA spatial threshold for astrocyte calcium surgePreprint
Lines, J., Baraibar, A. M., Nanclares, C., Martín, E. D., Aguilar, J., Kofuji, P., Navarrete, M., & Araque, A. (2023) · eLife · doi:10.7554/elife.90046 · Cited by 32
“…et al., 2016 ; Nagai et al., 2021 ; Oliveira et al., 2015 ), and disruption of astrocyte calcium has been proposed to contribute to brain diseases ( Delekate et al., 2014 ; Jiang et al., 2016 ; Kuchibhotla et al., 2009 ; Lines et al., 2022 ; Nanclares et al., 2023 ; Tian et al., 2005 ; Yu et al.,…”
Le, H. T. T., Rimpiläinen, T., Saravanan, K. M., Murugesan, A., Yli-Harja, O. P., Candeias, N. R., & Kandhavelu, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-55194-8 · Cited by 23
Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
Sbai, O., Bazzani, V., Tapaswi, S., McHale, J., Vascotto, C., & Perrone, L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1166879 · Cited by 26
“Astrocytes are not only essential for the maintenance of neuronal health, but also are an important component implicated in synaptic transmission, they modulate brain energetics and cerebrovascular function (Delekate et al., 2014).”
BackgroundLia, A., Spiezio, A. D., Vitalini, L., Tore, M., Puja, G., & Losi, G. (2023) · Life · doi:10.3390/life13102038 · Cited by 36
“Initial experiments in APP-PS1 mice showed that amyloidosis is linked to an increased spontaneous somatic astrocyte Ca 2+ activity (Kuchibhotla et al. (2009) [252]) that is P2Y1R-mediated (Delekate et al. (2014) [253]).”
BackgroundORAI2 Down-Regulation Potentiates SOCE and Decreases Aβ42 Accumulation in Human Neuroglioma Cells
Scremin, E., Agostini, M., Leparulo, A., Pozzan, T., Greotti, E., & Fasolato, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155288 · Cited by 25
“It is worth noting that astrocytes are also directly involved in Aβproduction [26,55–58], while alterations in Ca2+-based excitability has been reported in astrocytes from FAD mouse models [54,72,73].”
BackgroundVerkhratsky, A., Zorec, R., Rodriguez, J. J., & Parpura, V. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_17 · Cited by 24
Role of tRNA-Derived Fragments in Neurological Disorders: a Review
Mathew, B. A., Katta, M., Ludhiadch, A., Singh, P., & Munshi, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03078-w · Cited by 27
Kelly, P., Sanchez-Mico, M. V., Hou, S. S., Whiteman, S. T., Russ, A., Hudry, E., Arbel‐Ornath, M., Greenberg, S. M., & Bacskai, B. J. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1988-22.2023 · Cited by 25
Bijelić, D. D., Milicevic, K. D., Lazarević, M. N., Miljković, D. M., Pristov, J. B., Savić, D. Z., Petković, B. B., Anđjus, P. R., Momčilović, M. B., & Nikolic, L. M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24699 · Cited by 25
“Moreover, purine-mediated astroglial signaling is enhanced in pathological states such as epilepsy (Alvarez-Ferradas et al., 2015), Alzheimer's disease (Delekate et al., 2014), or cerebral ischemia (Kuboyama et al., 2011).”
BackgroundSpontaneous and multifaceted ATP release from astrocytes at the scale of hundreds of synapses
Hatashita, Y., Wu, Z., Fujita, H., Kumamoto, T., Livet, J., Li, Y., Tanifuji, M., & Inoue, T. (2023) · Glia · doi:10.1002/glia.24392 · Cited by 26
“…symptoms (Cao et al., 2013; Jun et al., 2018; Wang et al., 2021) and pathological conditions promote hyperactive extracellular ATP signaling (Delekate et al., 2014; Illes et al., 2019; Wu et al., 2022), future studies revealing how the spontaneous purinergic signaling of astrocytes is…”
InfluentialDragić, M., Mitrović, N., Adžić, M., Nedeljković, N., & Grković, I. (2021) · ASN NEURO · doi:10.1177/17590914211044882 · Cited by 28
“…detrimental phenotype after TMT-induced neurotoxicity, since this receptor is also involved in the regulation of several cytokines/chemokines expression (Kuboyama et al., 2011), and causes astrocytic hyperactivity and dysfunction in an animal model of neurodegeneration (Delekate et al., 2014).”
BackgroundPurinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
Ribeiro, D. E., Petiz, L. L., Glaser, T., Oliveira‐Giacomelli, Á., Andrejew, R., Saab, F. D. A. R., Milanis, M. D. S., Campos, H. C., Arnaud-Sampaio, V. F., de Oliveira, S. L. B., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109371 · Cited by 24
Recent progress in translational research on neurovascular and neurodegenerative disorders
Demuth, H., Dijkhuizen, R. M., Farr, T. D., Gelderblom, M., Horsburgh, K. J., Iadecola, C., McLeod, D. D., Michalski, D., Murphy, T. H., Orbe, J., et al. (2017) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-160690 · Cited by 23
“These data suggest that, similar to AD (Delekate et al., 2014), astrocytes might be centrally involved in the pathophysiology of VCI, and that anti-inflammatory interventions may prove therapeutically beneficial.”
Self-citationMüller, M. S., & Taylor, C. W. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14119 · Cited by 21
“…pathophysiological processes, including gliotransmitter release, cytokine expression, nociception, regulation of synaptic strength, astrogliosis, ischaemia-induced injury and Alzheimer’s disease (Franke et al. 2001; Duan et al. 2003; Pascual et al. 2005; Lammer et al. 2006; Delekate et al. 2014).”
BackgroundHuffels, C. F. M., Osborn, L. M., Hulshof, L. A., Kooijman, L., Henning, L., Steinhäuser, C., & Hol, E. M. (2022) · Glia · doi:10.1002/glia.24137 · Cited by 22
Neuroglial Advances: New Roles for Established Players
Verkhratsky, A., Li, B., Niu, J., Lin, S.-S., Su, Y., Jin, W., Li, Y., Jiang, S., Yi, C., Shi, F., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70080 · Cited by 20
Kang, T. H., & Friedmann, T. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.042 · Cited by 18
In Vivo Two Photon Imaging of Astrocytic Structure and Function in Alzheimer’s Disease
Kelly, P., Hudry, E., Hou, S. S., & Bacskai, B. J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00219 · Cited by 20
“Reactive astrocytes associated with amyloid plaques exhibit an increased expression of the purinergic P2Y1 receptor (P2Y1R; Delekate et al., 2014) and transgenic mice that overexpress the P2Y1R exhibit spontaneous intercellular propagating calcium waves with increased amplitude that are independent of local neuronal a…”
BackgroundInfluentialMoldovan, R., Wenzel, B., Teodoro, R., Neumann, W., Dukić-Stefanović, S., Kraus, W., Rong, P., Deuther‐Conrad, W., Hey‐Hawkins, E., Krügel, U., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.006 · Cited by 19
Potential and Realized Impact of Astroglia Ca2 + Dynamics on Circuit Function and Behavior
Lim, E. Y., Ye, L., & Paukert, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.682888 · Cited by 22
Aldabbagh, Y., Islam, A., Zhang, W., Whiting, P. J., & Ali, A. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.822499 · Cited by 22
Ectonucleotidase activity and immunosuppression in astrocyte-CD4 T cell bidirectional signaling
Filipello, F., Pozzi, D., Proietti, M., Romagnani, A., Mazzitelli, S., Matteoli, M., Verderio, C., & Grassi, F. (2016) · Oncotarget · doi:10.18632/oncotarget.6914 · Cited by 22
“Indeed, Ca2+ signaling in astrocyte foot processes can influence blood flow through activation of phospholipase A2 (PLA2), arachidonic acid (AA) mobilization and production of vasoactive AA metabolites [36-40], with Ca2+ elevations being more common in vasoconstriction [41].”
BackgroundAlam, S., Afsar, S. Y., Wolter, M. A., Volk, L. M., Mitroi, D. N., Meyer zu Heringdorf, D., & van Echten-Deckert, G. (2023) · Cells · doi:10.3390/cells12141844 · Cited by 18
“Moreover, this study shows that P2Y1Rs are strongly expressed by reactive astrocytes surrounding the senile plaques and excludes the role of P2X receptors for astrocytic hyperactivity [33].”
BackgroundInfluentialThe Duality of Astrocyte Neuromodulation: Astrocytes Sense Neuromodulators and Are Neuromodulators
Lines, J., Corkrum, M., Aguilar, J., & Araque, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70054 · Cited by 24
“…and behavior have been documented in several animal models of diseases, such as Alzheimer's disease (Lines et al. 2021; Kuchibhotla et al. 2009; Delekate et al. 2014; Jo et al. 2014; Richetin et al. 2020), epilepsy (Tian et al. 2005), multiple sclerosis (Habbas et al. 2015), and stroke (Ding…”
Dias, L., Madeira, D., Dias, R., Tomé, Â. R., Cunha, R. A., & Agostinho, P. M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04492-y · Cited by 19
“In spite of this concluded impact of Aβ on ER-related Ca2+ management, we now observed that the ability of P2Y1R to control astrocytic Ca2+ responses was essentially preserved: thus, the effect of the P2Y1R agonist was preserved and a P2Y1R antagonist attenuated ATP-induced Ca2+ responses in astrocytes exposed to Aβ1-…”
BackgroundAutoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity
Baraibar, A. M., Colomer, T., Moreno‐García, A., Bernal‐Chico, A., Sánchez-Martín, E., Utrilla, C., Serrat, R., Gómez, E. S., Rodríguez-Antigüedad, A., Araque, A., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.010 · Cited by 21
“These observations are in line with recent reports of astrocyte hyperactivity in mouse models of AD using in vivo multiphoton microscopy (Delekate et al., 2014; Lines et al., 2022), although decreased calcium signaling has also been reported at early stages of Alheimer ’ s disease pathology (Shah…”
ResultIllés, P., Rubini, P., Ulrich, H., Yin, H., & Tang, Y. C. (2025) · MedComm · doi:10.1002/mco2.70177 · Cited by 21
“In vivo two-photon microscopy demonstrated in astrocytes of the somatosensory cortex the increase of spontaneous [Ca 2 + ] i transients in a mouse model of familial AD (APPPS1 mice [105]; Figure 3).”
Impaired Synaptic Plasticity Mechanisms in Alzheimer’s Disease
Ebrahimi, R., Golzari, Z., Heidari‐Foroozan, M., Khosravi, A., Sharghi, S. G., Saleh, M., Salarvandian, S., & Esmaeilpour, K. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01712-9 · Cited by 23
“…coverage of astrocytes retracts or becomes mislocalized, leading to diminished uptake of glutamate and increased spillover into extrasynaptic space—further disrupting synaptic signaling and promoting the activation of cell death pathways via extrasynaptic NMDA receptors (Delekate et al. 2014).”
Astrocytes exhibit diverse Ca2+ changes at subcellular domains during brain aging
Ding, F., Liang, S., Li, R., Yang, Z., He, Y., Yang, S., Duan, Q., Zhang, J., Lyu, J., Zhou, Z., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1029533 · Cited by 18
“In addition, astrocytic network alterations have been reported in neurodegenerative disorders, which induced the elevated resting Ca2+ and more frequent Ca2+ transients in astrocytic network (Kuchibhotla et al., 2009; Delekate et al., 2014).”
BackgroundMitochondrial Ca2+ Signaling and Bioenergetics in Alzheimer’s Disease
Arnst, N., Redolfi, N., Lia, A., Bedetta, M., Greotti, E., & Pizzo, P. (2022) · Biomedicines · doi:10.3390/biomedicines10123025 · Cited by 20
Masutomi, H., Kawashima, S., Kondo, Y., Uchida, Y., Jang, B., Choi, E., Kim, Y., Shimokado, K., & Ishigami, A. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23959 · Cited by 19
“Reactive astrocytes represent a universal defense mechanism of the brain to protect from acute and chronic injury and are also an early and very prominent feature of Alzheimer disease (AD) (Delekate et al., 2014).”
BackgroundHypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases
Bhatia, D., Ardekani, M. S., Shi, Q., & Movafagh, S. (2017) · Hypoxia and Human Diseases · doi:10.5772/66089 · Cited by 17
“P2Y1 receptors are strongly expressed by reactive astrocytes, and blockade of P2Y1 receptors can reduce astrocytic hyperactivity back to normal [52].”
BackgroundPotential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials
Ferreira, N. C. D. S., Alves, L. A., & Soares‐Bezerra, R. J. (2019) · Current Drug Targets · doi:10.2174/1389450120666190213095923 · Cited by 18
Božić, M., Verkhratsky, A., Zorec, R., & Stenovec, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03350-8 · Cited by 17
Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
Nobili, P., Shen, W., Milicevic, K. D., Pristov, J. B., Audinat, É., & Nikolic, L. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.900337 · Cited by 21
“Literature data, however, show that expression of P2Y1Rs is mainly detected in astrocytes (Franke et al., 1999; Jourdain et al., 2007; Kuboyama et al., 2011; Pascual et al., 2012; Delekate et al., 2014).”
BackgroundHousing Complexity Alters GFAP-Immunoreactive Astrocyte Morphology in the Rat Dentate Gyrus
Salois, G., & Smith, J. S. (2016) · Neural Plasticity · doi:10.1155/2016/3928726 · Cited by 18
Epilepsy therapy beyond neurons: Unveiling astrocytes as cellular targets
Chen, Y., Hu, J., Zhang, Y., Peng, L., Li, X., Li, C., Wu, X., & Wang, C. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01035 · Cited by 20
“Additionally, blockade of the purinergic G protein-coupled receptor P2Y1 has been shown to normalize network dysfunction and cognition by counteracting astrocytic hyperactivity in an Alzheimer’s disease model (Delekate et al., 2014; Reichenbach et al., 2018).”
Recent Progress in Ionic Coassembly of Cationic Peptides and Anionic Species
Xie, X., Zheng, T., & Li, W. (2020) · Macromolecular Rapid Communications · doi:10.1002/marc.202000534 · Cited by 16
Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer’s Disease Rat Model
Ebel, D. L., Torkilsen, C. G., & Ostrowski, T. D. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160974 · Cited by 15
Huffels, C. F. M., Osborn, L. M., Cappaert, N. L. M., & Hol, E. M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25042 · Cited by 13
Platelet P2Y1 receptor exhibits constitutive G protein signaling and β-arrestin 2 recruitment
Ribes, A. M., Garcia, C., Gratacap, M., Kostenis, E., Martinez, L. O., Payrastre, B., Sénard, J., Galès, C., & Pons, V. (2023) · BMC Biology · doi:10.1186/s12915-023-01528-y · Cited by 16
“Interestingly, astrocyte hyperactivity, which is an important contributor to neuronal-glial network dysfunction in Alzheimer’s disease, was driven by enhanced P2Y1-R expression and activity [46].”
BackgroundFaakye, J., Nyúl‐Tóth, Á., Gulej, R., Csík, B., Tarantini, S., Shanmugarama, S., Prodan, C. I., Mukli, P., Yabluchanskiy, A., Conley, S. M., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00839-w · Cited by 16
“Extravasated SR101 was subsequently taken up by astrocytes [56–59].”
BackgroundRegulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease
Juvenal, G. D. A., Higa, G. S. V., Marques, L. B., Zampieri, T. T., Viana, F. J. C., Britto, L. R. G., Tang, Y. C., Illés, P., Virgilio, F. D., Ulrich, H., et al. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10034-x · Cited by 19
Pappas, A. C., Koide, M., & Wellman, G. C. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16650911 · Cited by 17
“These results, however, do not rule out the possibility that quantal (i.e., action potential-independent) neurotransmitter release or vesicular-mediated gliotransmitter release underlies the emergence of eHACSs after SAH.”
BackgroundResultInfluentialMitroshina, Е. V., Pakhomov, A. M., Krivonosov, M., Yarkov, R. S., Gavrish, M. S., Shkirin, A. V., Ivanchenko, M., & Vedunova, M. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415928 · Cited by 17
“For example, the hyperactivity of astrocytes adjacent to amyloid plaques mediated by activation of metabotropic purinergic receptors has been described [46,47].”
Benarroch, E. E. (2016) · Neurology · doi:10.1212/wnl.0000000000003019 · Cited by 16
Ding, N., Jiang, J. H., Tian, H., Wang, S., & Li, Z. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01354 · Cited by 19
Yu, L., Wang, Y., Zhang, H., Li, M., Chen, G., Hao, J., & Xie, M. (2022) · Purinergic Signalling · doi:10.1007/s11302-021-09827-1 · Cited by 14
“In previous studies, it has been demonstrated that P2Y1R is involved in the regulation of depression [42], anxiety [49], Alzheimer’s disease [50], arterial thrombosis [51], and brain ischemia [52].”
BackgroundWirth, S., Schlößer, A., Beiersdorfer, A., Schweizer, M., Woo, M. S., Friese, M. A., Lohr, C., & Grochowska, K. M. (2024) · Glia · doi:10.1002/glia.24539 · Cited by 12
“To induce Ca 2 + transients, we utilized the purinergic receptor agonist ADP, which activates the P2Y1 receptor and the downstream Gq-dependent pathway in vitro and in vivo (Delekate et al., 2014; Doengi et al., 2008; Fumagalli et al., 2003).”
BackgroundMethodLigand-receptor interactions: A key to understanding microglia and astrocyte roles in epilepsy
Thergarajan, P., O'Brien, T. J., Jones, N. C., & Ali, I. Y. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.110219 · Cited by 13
“Elevated levels of P2Y1R expression have been observed in various neurological disorders, including but not limited to epilepsy [9,145], mechanical injury [72], ischemia [110], and Alzheimer ’ s disease [53,136].”
Orai2 channel regulates prostaglandin E2 production in TNFα / IL1α ‐stimulated astrocytes
Nakajima, H., Fujita, S., Kakae, M., Nagayasu, K., Oh‐hora, M., Shirakawa, H., & Kaneko, S. (2022) · Glia · doi:10.1002/glia.24188 · Cited by 13
Babiec, L., Wilkaniec, A., Matuszewska, M., Pałasz, E., Cieślik, M., & Adamczyk, A. (2023) · Brain Sciences · doi:10.3390/brainsci13071088 · Cited by 13
Eraso‐Pichot, A., Larramona‐Arcas, R., Orri, E. V., Villalonga, R., Pardo, L., Galea, E., & Masgrau, R. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2397-5 · Cited by 14
“hyperactivity is a hallmark of epilepsy [27] and neurodegenerative diseases [29, 55].”
Background
Metadata
- Authors
- Delekate, A., Füchtemeier, M., Schumacher, T., Ulbrich, C., Foddis, M., & Petzold, G. C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- Charité – Universitätsmedizin Berlin (DE)
- University Hospital Bonn (DE)
- Corresponding author
- Petzold, Gabor C.
- Venue
- Nature Communications
- Published
- 2014-11-19
- Volume
- 5
- Issue
- 1
- Pages
- 5422-5422
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2052870901
- Cited by
- 332
- References
- 68
- Citations by year
- 2026: 31 · 2025: 30 · 2024: 26 · 2023: 41 · 2022: 33 · 2021: 30 · 2020: 28 · 2019: 27 · 2018: 24 · 2017: 20 · 2016: 24 · 2015: 18
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, astrocytes, P2Y1 receptor, purinergic signaling, reactive astrogliosis, amyloid plaques, connexin hemichannels, nucleotide release, ADP, cerebral blood flow, P2X receptors
- MeSH terms
- Adenosine Triphosphate, Alzheimer Disease, Animals, Astrocytes, Cerebrovascular Circulation, Disease Models, Animal, Humans, Mice, Transgenic, Signal Transduction, Amyloid beta-Protein Precursor, Calcium Signaling, Microscopy, Fluorescence, Multiphoton, Mice, Plaque, Amyloid, Receptors, Purinergic P2Y1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.